Finance

Lists
Why is 002365 down 3,46%?
Dive Deeper
002365:SHE
Qianjiang Yongan Pharmaceutical Co Ltd
11,99 CN¥
-3,46%
(-0,43) 1D
16 қаз., 15:04:33 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002365...
Open
12,55 CN¥
High
12,82 CN¥
Low
11,88 CN¥
Mkt. cap
3,81 млрд
Avg. vol.
27,12 млн
Volume
15,35 млн
Dividend
0,83%
Quarterly dividend
0,03 CN¥
Ex-dividend date
2026 ж. 11 мау.
P/E ratio
65,00
52-wk high
19,32 CN¥
52-wk low
9,82 CN¥
EPS
0,18 CN¥
Shares outstanding
294,68 млн
No. of employees
912
Open
12,55 CN¥
High
12,82 CN¥
Low
11,88 CN¥
Mkt. cap
3,81 млрд
Avg. vol.
27,12 млн
Volume
15,35 млн
Dividend
0,83%
Quarterly dividend
0,03 CN¥
Ex-dividend date
2026 ж. 11 мау.
P/E ratio
65,00
52-wk high
19,32 CN¥
52-wk low
9,82 CN¥
EPS
0,18 CN¥
Shares outstanding
294,68 млн
No. of employees
912
News stories
From web sources and news partners
www.pei-privaterealestate.com
www.pei-privaterealestate.com
·
16 минут бұрын
NASDAQ report tracks insurer shift toward real estate debt strategies in 2025
Forbes
Forbes
·
14 минут бұрын
SK Hynix Opened Nasdaq. Will Seoul Keep It Open?
About Qianjiang Yongan Pharmaceutical Co Ltd
CEO-
Employees912
Founded2001 ж. 18 мау.
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
209,77 млн
206,02 млн
235,90 млн
327,81 млн
Cost of goods sold
169,02 млн
173,34 млн
188,18 млн
232,78 млн
Cost of revenue
169,02 млн
173,34 млн
188,18 млн
232,78 млн
Research and development expenses
8,72 млн
4,79 млн
8,62 млн
12,19 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
32,66 млн
22,80 млн
23,64 млн
27,21 млн
Operating expense
44,57 млн
30,70 млн
37,00 млн
47,52 млн
Total operating expenses
213,59 млн
204,04 млн
225,17 млн
280,30 млн
Operating income
-3,82 млн
1,98 млн
10,73 млн
47,51 млн
Other non operating income
1,12 млн
-1,92 млн
-3,03 млн
2,61 млн
EBT including unusual items
8,54 млн
-8,14 млн
9,16 млн
48,78 млн
EBT excluding unusual items
9,56 млн
5,39 млн
13,05 млн
48,05 млн
Income tax expense
753,52 м.
1,01 млн
1,17 млн
13,99 млн
Effective tax rate
8,82%
-12,40%
12,78%
28,67%
Other operating expenses
2,44 млн
2,38 млн
3,08 млн
3,04 млн
Net income
13,00 млн
-3,00 млн
7,74 млн
35,67 млн
Net profit margin
6,20%
-1,46%
3,28%
10,88%
Earnings per share
-
-
-
-
Interest and investment income
14,15 млн
5,67 млн
5,37 млн
4,18 млн
Interest expense
-217,73 м.
-203,05 м.
-10,40 мың
-20,88 мың
Net interest expenses
13,93 млн
5,47 млн
5,36 млн
4,15 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
24,35 млн
31,15 млн
39,90 млн
75,68 млн
Gain or loss from assets sale
32,63 мың
-185,68 м.
-
-8,23 мың
AI content may include mistakes. Learn more
Google қолданбалары